Cite
Qi YA, Maity TK, Gao S, et al. Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma. Cancers (Basel). 2021;13(19)doi: 10.3390/cancers13194977.
Qi, Y. A., Maity, T. K., Gao, S., Gong, T., Bahta, M., Venugopalan, A., Zhang, X., & Guha, U. (2021). Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma. Cancers, 13(19), . https://doi.org/10.3390/cancers13194977
Qi, Yue A, et al. "Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma." Cancers vol. 13,19 (2021). doi: https://doi.org/10.3390/cancers13194977
Qi YA, Maity TK, Gao S, Gong T, Bahta M, Venugopalan A, Zhang X, Guha U. Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma. Cancers (Basel). 2021 Oct 04;13(19). doi: 10.3390/cancers13194977. PMID: 34638461; PMCID: PMC8507780.
Copy
Download .nbib